Consultancy
CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?
Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients. Aduhelm received a controversial accelerated approval from the FDA in June 2021, a decision that balanced the lack of consensuses among the scientif...
Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D
Despite the rapid scientific advances with new targets, modalities, and biomarkers, the return on invested capital (ROIC) in novel therapeutics remains low. The problem stems from the large investment needed, high risks of failure, and long timelines until revenues can be realized. This...
Infertility - A public health concern
The World Health Organization (WHO) estimates that one out of six people globally are impacted by the inability to conceive a child. Over the last decade, countries around the world have seen a decline in total fertility rates, most notably in economically developed countries withi...
Chris Dunn shortlisted as a Top UK Business Adviser
Chris Dunn has been shortlisted for the UK’s Top Business Advisers Awards. Chris who delivers consulting, coaching, and mentoring services to help entrepreneurs grow their business was picked from hundreds of advisers from around the UK for his outstanding work in business development. ...
The EpiCentre is working with Microsoft to support innovative early-stage businesses
Oxford Innovation Space that manages The EpiCentre at Haverhill and Microsoft have announced that they are working together to support the growth of innovative early-stage businesses. ...
Internationalising MedTech Innovation
This session will provide a comprehensive pathway for EU-based MedTech innovators, covering market analysis, planning, compliance, and more. Each topic has been carefully selected to ensure you leave with actionable insights and a clear roadmap for entering and thriving in these new mar...
Keytruda LoE: A seismic shift for oncology?
Immune checkpoint inhibitors (ICIs) have changed the face of oncology treatment since their initial entry in the early 2010s. Driven mostly by the group of PD-1 and PD-L1 molecules, they have resulted in cumulative 2023 global revenues exceeding $45 billion USD. Within the PD-...
Enhancing Data Governance with Secure Data Environment Portals
Join us to explore the Thames Valley and Surrey Secure Data Environment (SDE) and how the innovative Mauro solution, developed in collaboration between Oxford University (OU), Oxford University Hospital (OUH) and System C, is supporting the SDE in streamlining data governance and securi...
Practical Essentials of Sample Preparation Course | 16th - 19th December 2024
Join our 4-day virtual course scheduled for 16th - 19th December, 2024
Join Anthias Consulting's Applied Interpretation of LC-MS Mass Spectra Course
This course on 2nd - 4th December 2024, is an introduction to mass spectral interpretation presenting the fundamental tools and rules when interpreting full-scan LC-MS data. You will benefit from a greater understanding of how to interpret the mass spectra produced by Electrospray Ionis...